share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

福泰製藥 | 144:擬議出售證券
美股sec公告 ·  06/12 10:01
Moomoo AI 已提取核心訊息
Vertex Pharmaceuticals Inc. officer, Atkinson Edward Morrow III, is set to sell 7,288 shares of common stock on 06/12/2024, with an aggregate market value of approximately $3,483,664. The shares were acquired on 06/10/2024 through restricted stock vesting as part of compensation from the issuer. This transaction follows a period where no securities were sold by Morrow in the past three months, as per the latest filings.
Vertex Pharmaceuticals Inc. officer, Atkinson Edward Morrow III, is set to sell 7,288 shares of common stock on 06/12/2024, with an aggregate market value of approximately $3,483,664. The shares were acquired on 06/10/2024 through restricted stock vesting as part of compensation from the issuer. This transaction follows a period where no securities were sold by Morrow in the past three months, as per the latest filings.
Vertex製藥公司的高管Atkinson Edward Morrow III,計劃於2024年06月12日賣出7,288股普通股,其市值約爲3,483,664美元。這些股票是在2024年06月10日通過股票限制解除而獲得的補償部分。根據最新的申報文件,此次交易是Morrow在過去三個月內沒有出售證券後的第一次交易。
Vertex製藥公司的高管Atkinson Edward Morrow III,計劃於2024年06月12日賣出7,288股普通股,其市值約爲3,483,664美元。這些股票是在2024年06月10日通過股票限制解除而獲得的補償部分。根據最新的申報文件,此次交易是Morrow在過去三個月內沒有出售證券後的第一次交易。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息